Although the world is almost polio-free, vaccination remains necessary to prevent future outbreaks. Therefore, on assignment by the World Health Organization, Intravacc developed a new and promising Sabin-IPV polio vaccine. We used our proven platform technologies to swiftly develop an affordable and safe production technology. In recent clinical studies, Sabin-IPV was shown to be safe and immunogenic in adults and infants. Currently, this production technology and related quality controls are actively being transferred by hands-on training to local vaccine manufacturers in emerging economies. As a result, manufacturers in for example China, South Korea and India are enabled to safely produce the Sabin-IPV vaccine to vaccinate their local population.
Turning big data into a valuable resource is a challenge that many online platforms face. Since its beginnings as a Dutch start-up, Booking.com has grown exponentially to become one of the world's leading e-commerce companies by successfully leveraging consumer behavior data to continuously optimise its website and mobile apps. With a singular mandate to focus on the customer experience and complete freedom to test new ideas, Booking.com employees are in the driver's seat for all of the company's innovations. This data-driven, democratic approach to product development yields up to 1,000 small-step experiments on a daily basis that drive industry-leading breakthroughs.
The Venco Campus is a unique concept where sustainability, innovation, flexibility and transparency are the basis of a future-proof shelter for various companies in the poultry industry. With the completely new Venco Campus a target has been set to serve as an international knowledge, research and innovation center for the poultry industry. Hence, the entire poultry world is welcome in this particular building. Through cross-pollination, the Venco Campus intends to play its part so that the sector can maintain its leading position in the world.The campus is BREEAM-NL Outstanding certified for its energy efficiency and sustainability.
Researchers at the Hubrecht Institute and the University Medical Center (UMC) Utrecht have found a way to multiply human tissue under laboratory conditions. They accomplished this by developing a culturing technique for human liver and pancreatic stem cells. Tissue comparable to the volume and weight of a full-grown human liver can be grown over a period of four months, without genetic mutations. With this technique, individual patients' tissue can be cultured and the efficacy of various cancer drugs can be tested before patients receive the actual treatment. This could make highly individualised treatment possible, which could improve treatment benefit for patients.